Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Combined Laser and Nanotube Therapy Destroys Kidney Tumors

By LabMedica International staff writers
Posted on 14 Aug 2009
A novel cancer treatment has been described that is based on carbon nanotubes that heat up when exposed to laser light and then destroy tumors into which they have been injected.

Investigators from Wake Forest University (Winston Salem, NC, USA) evaluated several protocols that involved injection of multiwalled carbon nanotubes (MWCNTs) directly into kidney tumors in a population of laboratory mice. More...
After injection of the nanotubes, the area of the tumors was subjected to various levels of laser light for different periods.

Data published in the July 20, 2009, online edition of the journal Proceedings of the [U.S.] National Academy of Sciences (PNAS) revealed that injection of 100 micrograms of MWCNT followed by illumination for 30 seconds with a low power (three-watt) laser resulted in complete ablation of tumors and a more than nine month period of lasting remission in 80% of the mice. In contrast, mice that received no treatment, mice that received nanotubes with no laser treatment, and mice that received laser treatment without nanotubes died about 30 days into the study. The treatment caused minimal local toxicity with no evidence of systemic toxicity.

"You can actually watch the tumors shrinking until, one day, they are gone,” said senior author Dr. Suzy Torti, professor of biochemistry at Wake Forest University. "Not only did the mice survive, but they maintained their weight, did not have any noticeable behavioral abnormalities and experienced no obvious problems with internal tissues. As far as we can tell, other than a transient burn on the skin that did not seem to affect the animals and eventually went away, there were no real downsides--that is very encouraging. When dealing with cancer, survival is the endpoint that you are searching for. It is great if you can get the tumor to shrink, but the gold standard is to make the tumor shrink or disappear and not come back. It appears that we have found a way to do that.”

Related Links:
Wake Forest University



Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Clinical Chemistry System
P780
ESR Analyzer
TEST1 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.